The Hackensack Meridian Center for Discovery and Innovation (CDI), hosted the 34th annual symposium of the Mid-Atlantic Biosafety Symposium on…
Author: Steve Bove
Hackensack Meridian CDI Scientists Develop ‘CATCHER’ for Crucial Biomarkers
Tiny genetic markers, circulating in the blood, have shown great promise in diagnosing and treating disease. Yet identifying and harvesting these…
CDI Head Perlin Named to ROI-NJ Power List for COVID-19 Response
David Perlin, Ph.D., the chief scientific officer and senior vice president of the Center for Discovery and Innovation, was named…
CDI Scientists Publish Results of Novel COVID-19 Test
The viral diagnostic test for COVID-19, developed and implemented by scientists from the Hackensack Meridian Center for Discovery and Innovation…
Immune Mechanism Could Boost Vaccine Efficacy, CDI Lab Finds
Effective vaccines may depend on the ability of a key cellular mechanism to limit the immune system’s “brakes” on developing…
Hackensack Meridian Health Awarded $5.5 Million to Continue Convalescent Plasma Work for COVID-19
Treatments using antibodies of pandemic survivors bolstered by federal grant Researchers and clinical experts at Hackensack Meridian Health, New Jersey’s largest and…
CDI Lab Tackles ‘Long-Standing Controversy’ in Certain Leukemias
New research challenges a widely accepted view of beta-catenin’s role in acute myeloid leukemia (AML) — impacting the development of…
The CDI Experts: Gengenbacher and the Fight Against Global Killer TB
COVID-19 has killed 2 million people worldwide over the last year, according to estimates. But year after year in the…
CDI Named Top Business Incubator by NJBIZ
Hackensack Meridian Health was named the top health care network in the state in the NJBIZ 2020 Reader Rankings. One…
Loudig Talks Better Biomarkers, Diagnostics, in Virtual Talk
Performing diagnostics earlier, less invasively, and more accurately than ever could save untold lives. For Oliver Loudig, Ph.D., the Center…